PABLO
ROJO CONEJO
Profesor titular de universidad
Hospital Universitario 12 de Octubre
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (152)
2024
-
High mortality following early initiation of antiretroviral therapy in infants living with HIV from three African countries
eClinicalMedicine, Vol. 73
-
Low unspliced cell-associated HIV RNA in early treated adolescents living with HIV on long suppressive ART
Frontiers in Immunology, Vol. 15
-
Plasma Protein Biomarkers Distinguish Multisystem Inflammatory Syndrome in Children From Other Pediatric Infectious and Inflammatory Diseases
The Pediatric infectious disease journal, Vol. 43, Núm. 5, pp. 444-453
-
Randomised multicentre effectiveness trial of rapid syndromic testing by panel assay in children presenting to European emergency departments with acute respiratory infections-trial protocol for the ADEQUATE Paediatric trial
BMJ Open, Vol. 14, Núm. 4
-
Remdesivir for COVID-19 in Hospitalized Children: A Phase 2/3 Study
Pediatrics, Vol. 153, Núm. 3
-
Renal Function Impairment in Children With Congenital Cytomegalovirus Infection: A Cross-sectional Study
The Pediatric infectious disease journal, Vol. 43, Núm. 3, pp. 257-262
-
Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission
Nature Medicine
-
Swissped-RECOVERY: masked independent adjudication for the interpretation of non-randomised treatment in a two-arm open-label randomised controlled trial (methylprednisolone vs immunoglobulins) in Paediatric Inflammatory Multisystem Syndrome Temporally Associated with SARSCoV-2 (PIMS-TS) involving 10 secondary and tertiary paediatric hospitals in Switzerland
BMJ Open, Vol. 14, Núm. 4
-
T-Cell Immune Responses in Newborns and Long-Term Sequelae in Congenital Cytomegalovirus Infection (CYTRIC Study)
Journal of Pediatrics, Vol. 272
-
Transmitted Drug Resistance and HIV Diversity Among Adolescents Newly Diagnosed With HIV in Spain
Pediatric Infectious Disease Journal, Vol. 43, Núm. 1, pp. 40-48
-
Twice-Daily Dosing of Dolutegravir in Infants on Rifampicin Treatment: A Pharmacokinetic Substudy of the EMPIRICAL Trial
Clinical Infectious Diseases, Vol. 78, Núm. 3, pp. 702-710
2023
-
Acute respiratory distress syndrome after SARS-CoV-2 infection on young adult population: International observational federated study based on electronic health records through the 4CE consortium
PLoS ONE, Vol. 18, Núm. 1 January
-
Adeno-associated virus 2 infection in children with non-A–E hepatitis
Nature, Vol. 617, Núm. 7961, pp. 555-563
-
Brief Report: Suboptimal Lopinavir Exposure in Infants on Rifampicin Treatment Receiving Double-dosed or Semisuperboosted Lopinavir/Ritonavir: Time for a Change
Journal of Acquired Immune Deficiency Syndromes, Vol. 93, Núm. 1, pp. 42-46
-
Clinical phenotypes and outcomes in children with multisystem inflammatory syndrome across SARS-CoV-2 variant eras: a multinational study from the 4CE consortium
eClinicalMedicine, Vol. 64
-
Diagnosis of Multisystem Inflammatory Syndrome in Children by a Whole-Blood Transcriptional Signature
Journal of the Pediatric Infectious Diseases Society, Vol. 12, Núm. 6, pp. 322-331
-
First-Line Antituberculosis Drug Concentrations in Infants With HIV and a History of Recent Admission With Severe Pneumonia
Journal of the Pediatric Infectious Diseases Society, Vol. 12, Núm. 11, pp. 581-585
-
Genomic investigations of unexplained acute hepatitis in children
Nature, Vol. 617, Núm. 7961, pp. 564-573
-
Long-term kidney function recovery and mortality after COVID-19-associated acute kidney injury: An international multi-centre observational cohort study
eClinicalMedicine, Vol. 55
-
Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial
The Lancet Child and Adolescent Health, Vol. 7, Núm. 10, pp. 718-727